Crystal structure of a designed Respiratory Syncytial Virus Immunogen in complex with Motavizumab
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| D [auth A] | Ribosomal_S13_N | e4jlrA1 | A: beta barrels | X: DEATH domain | H: 40S ribosomal protein S13 N-terminal domain | T: 40S ribosomal protein S13 N-terminal domain | F: Ribosomal_S13_N | ECOD (v294.2) |
| A [auth H] | Acylphosphatase | e4jlrH1 | A: beta barrels | X: FAD-linked reductases, C-terminal domain-like | H: FAD-linked reductases-C | T: FAD-linked reductases-C | F: Acylphosphatase | ECOD (v294.2) |
| E [auth B] | Ribosomal_S13_N | e4jlrB1 | A: beta barrels | X: DEATH domain | H: 40S ribosomal protein S13 N-terminal domain | T: 40S ribosomal protein S13 N-terminal domain | F: Ribosomal_S13_N | ECOD (v294.2) |
| B [auth L] | VEGFR-1-like_Ig-like | e4jlrL3 | A: beta barrels | X: Fusion glycoprotein F2 | H: MoeA-I/Ornithine decarboxylase-C/Reverse ferredoxin-like domain in RNA-polymerase | T: MoeA-I/Ornithine decarboxylase-C/Reverse ferredoxin-like domain in RNA-polymerase | F: VEGFR-1-like_Ig-like | ECOD (v294.2) |
| F [auth C] | EF-hand_1, EF-hand_7 | e4jlrC1 | A: beta barrels | X: P-loop domains-like | H: Rubredoxin-related | T: Rubredoxin-related | F: EF-hand_1, EF-hand_7 | ECOD (v294.2) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| D [auth A] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| A [auth H] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| E [auth B] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| B [auth L] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| F [auth C] | 1.10.132.20 | Mainly Alpha | Orthogonal Bundle | Topoisomerase I | Chain A, domain 4 | CATH (4.3.0) |
| C [auth S] | 1.10.132.20 | Mainly Alpha | Orthogonal Bundle | Topoisomerase I | Chain A, domain 4 | CATH (4.3.0) |
IMGT Antibody Annotation IMGT Database Homepage
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|---|---|---|---|---|---|---|---|
| A [auth H], D [auth A] | INN name | VH-CH1 | Humanized (humanized) | IGHV2-70*01, IGHV2-70*13, IGHJ6*03, IGHG1*01, IGHG1*02, IGHG1*04 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202618-0) |
| B [auth L], E [auth B] | INN name | L-KAPPA | Humanized (humanized) | IGKV1-5*01, IGKJ4*01, IGKJ4*02, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202618-0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| A [auth H], D [auth A] | Heavy Chain | IGHV2 | - | rsv_1isea designed scaffold | SAbDab (2026-05-15) |
| B [auth L], E [auth B] | Light Chain | IGKV1 | Kappa | rsv_1isea designed scaffold | SAbDab (2026-05-15) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| A [auth H], D [auth A] | Motavizumab | Respiratory Syncytial Virus Glycoprotein F | Therapeutic SAbDab (2026-05-15) |
| B [auth L], E [auth B] | Motavizumab | Respiratory Syncytial Virus Glycoprotein F | Therapeutic SAbDab (2026-05-15) |
